Enrique de Alava

Has grant

Professor

Universidad de Sevilla

Spain

Research Interests

Explore related searches

Professors in Spain Professors in Immunology Immunology professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Enrique de Alava is a faculty member at the University of Seville, Spain. His research focuses on cancer genomics, examining mechanisms in uveal melanoma, pediatric sarcomas, and advanced non-small cell lung cancer, as evidenced by his recent publications. He explores novel therapeutic approaches, including immunotherapy and CAR T cell technologies, aimed at treating various sarcomas through advanced genetic analysis.

Recent Grants

Grant: Close

EURO EWING Consortium – International Clinical Trials to Improve Survival from Ewing Sarcoma (ECC)

Open Date: 2013-12-01

Close Date: 2019-12-01

Grant: Close

European Clinical trials in Rare Sarcomas within an integrated translational trial network (EUROSARC)

Open Date: 2013-01-01

Close Date: 2019-01-01

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

SPAIN

View details

Adam Byron

Lecturer

The University of Manchester

UNITED KINGDOM

View details

Florencia Cidre-Aranaz

Deputy Head of Division & Team Leader

German Cancer Research Center (DKFZ)

GERMANY

View details

Esther Conde

Universidad Complutense de Madrid

SPAIN

View details

Jason T. Yustein

Emory University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Enrique de Alava

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (20)

Costs of biomarker testing in advanced non‐small cell lung cancer: a global study comparing next‐generation sequencing and single‐gene testing

Chromosomal 3p loss and 8q gain drive vasculogenic mimicry via HIF-2α and VE-cadherin activation in uveal melanoma

Comprehensive DSRCT multi-omics analyses unveil CACNA2D2 as a diagnostic hallmark and super-enhancer-driven EWSR1::WT1 signature gene.

Genomic and phenotypic stability of fusion-driven pediatric sarcoma cell lines

Characterization of Vitronectin Effect in 3D Ewing Sarcoma Models: A Digital Microscopic Analysis of Two Cell Lines

Epithelioid haemangioma after bone surgery: an event not previously described

Identification of Novel/Rare EWSR1 Fusion Partners in Undifferentiated Mesenchymal Neoplasms

A global collaboRAtive study of CIC-rearranged, BCOR::CCNB3-rearranged and other ultra-rare <i>unclassified</i> undifferentiated small round cell sarcomas (GRACefUl)

ALPL-1 is a target for chimeric antigen receptor therapy in osteosarcoma

An innovative tailored CAR T cell-redirecting immunotherapy for the treatment of metastatic and refractory Ewing Sarcoma

Endoglin and MMP14 Contribute to Ewing Sarcoma Spreading by Modulation of Cell–Matrix Interactions

An international working group consensus report for the prioritization of molecular biomarkers for Ewing sarcoma

Ewing Sarcoma Meets Epigenetics, Immunology and Nanomedicine: Moving Forward into Novel Therapeutic Strategies

Small round cell sarcomas

Cost-effectiveness analysis of molecular diagnosis by next-generation sequencing versus sequential single testing in metastatic non-small cell lung cancer patients from a south Spanish hospital perspective

Current status of precision medicine in pediatric oncology in Spain: a consensus report by the Spanish Society of Paediatric Haematology and Oncology (SEHOP)

Current status of precision medicine in pediatric oncology in Spain: a consensus report by the Spanish Society of Paediatric Haematology and Oncology (SEHOP)

Gastrointestinal stromal tumours: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up

Molecular diagnosis in non-small-cell lung cancer: expert opinion on ALK and ROS1 testing

Molecular diagnosis in non-small-cell lung cancer: expert opinion on <i>ALK</i> and <i>ROS1</i> testing.

Collaborators (14)

Carmelo Bernabeu

Patrick Leavey

FCO. JAVIER ALONSO GARCÍA DE LA ROSA

Kelly M. Bailey

Alexander Bishop

Paul Hofman

Masanori Hayashi

Federico Rojo

James Amatruda

Víctor Sánchez-Margalet

Adam Byron

Florencia Cidre-Aranaz

Esther Conde

Jason T. Yustein

Make your next move.